Procalcitonin as a biomarker in respiratory tract infection. - Wikidata - wikimedia - TriplyDB

Procalcitonin as a biomarker in respiratory tract infection.

Procalcitonin as a biomarker in respiratory tract infection.

http://www.wikidata.org/entity/Q37860806

about

Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.Respiratory review of 2012: pneumonia.Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature Inflammatory response in mixed viral-bacterial community-acquired pneumonia Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network Diagnostic value of procalcitonin and apo-e in extrahepatic biliary atresia.Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection.Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study.Valuable hematological indicators for the diagnosis and severity assessment of Chinese children with community-acquired pneumonia: Prealbumin.Role of Procalcitonin in Evaluation of the Severity of Acute Cholecystitis.The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro.Robust classification of bacterial and viral infections via integrated host gene expression diagnostics.The role of procalcitonin in respiratory infections.Viral Respiratory Infections of Adults in the Intensive Care Unit.Procalcitonin: present and future.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia.Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia.Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?Procalcitonin better than C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in predicting DNAemia in patients with sepsis.Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection.Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections.Evaluation of the use of novel biomarkers to augment antimicrobial stewardship program activities.Pediatric Community-Acquired Pneumonia in the United States: Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research.Procalcitonin and albumin as prognostic biomarkers in elderly patients with a risk of bacterial infection.Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia.

P2860

Q26799899-F9D3B9D8-A5F5-449D-B248-C09F9FE8FA0A Q26852219-CDDF5507-0360-4BD1-841B-98B5A9426AE8 Q28072571-721C9947-2226-4A35-8962-D3D523B32881 Q30416227-A5ADFDA7-A777-494A-BF45-CF71F96B4435 Q30423814-68F4A72B-D8AC-4987-9967-C6E6B0E8A735 Q33741319-7ED50E8C-6FC2-48E2-AB15-0460322821C2 Q33987876-E42125DE-87C1-4B28-B761-56ED2130D7A1 Q34357303-DCC0E2B6-F300-409A-9AA0-D5E48EC1B766 Q35176694-91356AEB-2B79-408E-A76C-98343A519282 Q35684222-0649A697-73F6-4C78-B04D-362452BA1D76 Q35797353-7D9203C7-0576-4AFC-A586-9649E94E9A29 Q35978983-983D4246-80F9-4293-9E16-DFB502953385 Q36250176-EE203853-65E1-47F1-8955-F1C8746A1F1A Q37065066-5FEEF556-126D-4800-A51A-B190A6D18ACE Q37328434-44723321-E0AE-434D-ACC0-247AFB2B3427 Q37468263-9EA13A72-01E9-4246-AA9D-ECC634E8B22F Q37608765-9462D651-F50E-44E6-B74D-88B403D6F465 Q37661557-35127381-593C-4000-B4D0-C4AE0BF39FFE Q37698010-A6F5C750-F75D-4F5A-993A-66FAB101DB66 Q37989831-671E5E6C-3BCD-4B0F-9655-4649B18E7457 Q38491990-B32D4E77-276B-4797-BB81-BDA7AF6A41A4 Q38544528-3939A88D-D35C-41EC-B409-93D7D38647C0 Q38637305-8840D90E-1EEE-458D-BBAD-22B4ECEAAF19 Q38710985-A1A0D56F-B759-4CE7-B511-338D46ACF5E0 Q38980653-7EE62AC1-8984-403C-A9DB-9250CB0A8EC0 Q39736769-1A2BA008-6480-4C47-BB7C-F7E49EBEEB55 Q40243731-C51CDCDD-DC14-42FA-984E-393DDF1207B5 Q40500674-BDF2FFC5-2DE3-48BC-93E5-EF55529FDE4A Q41750946-99CF4D39-365C-4E30-843E-73FB44471F80 Q43965327-A1A3DA36-245F-4FF8-AA35-9E4164B1BB59 Q45084324-B45E6601-D4D9-498F-8C34-7F00418D27F7 Q47102780-29556429-F26E-4D84-8968-D7025A5063A9 Q47160389-96BD4B57-B573-4BF2-A563-5C92CAB426A1 Q47282799-51EF7A92-DA99-45CE-A6B8-CF5EAB3BD392 Q47289498-A2C0FB90-DD45-48F0-A41C-08DAF25B6D45 Q47768505-2EE5ECF4-8400-4402-A190-C9CAB0D83314 Q54235383-450449C9-DD31-42E3-801A-B0F81C73C6A4 Q55255135-00A29F8C-A771-4D4F-9A03-978D24197FDF

P2860

Procalcitonin as a biomarker in respiratory tract infection.

http://www.wikidata.org/entity/Q37860806

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Procalcitonin as a biomarker in respiratory tract infection.

@en

Procalcitonin as a biomarker in respiratory tract infection.

@nl

type

label

Procalcitonin as a biomarker in respiratory tract infection.

@en

Procalcitonin as a biomarker in respiratory tract infection.

@nl

prefLabel

Procalcitonin as a biomarker in respiratory tract infection.

@en

Procalcitonin as a biomarker in respiratory tract infection.

@nl

P1433

Q37860806-014CCC15-89C9-4FC1-A0CE-925BC4194A84

P1476

Q37860806-24935AD9-8286-493B-8117-FD3EA5F64311

P2093

Q37860806-88BECF4B-1D7B-428F-9022-52446F4B687A

P2860

Q37860806-02319EE0-FC8F-4BDB-9968-15A74D594C16

Q37860806-0449A402-0B86-46B9-9689-EC6756D8DD26

Q37860806-0906151C-7F80-4DB1-83EA-647D60DD8E3F

Q37860806-148E2DFB-CFF7-420E-8F52-F8D91E39DCFE

Q37860806-153B09DD-A552-45E9-84EC-4AAB23CEB37B

Q37860806-256BF300-0650-4EAB-840B-29C842689371

Q37860806-286452BA-6279-49DF-97EB-E0F312FA3EFD

Q37860806-41C6A4BC-F5CA-453A-84F9-15B3A71028A8

Q37860806-422A2A97-9120-4197-BE6C-3DC406BA04FB

Q37860806-45F09ACC-A3E3-4A0E-96E2-62584459B2D0

P304

Q37860806-61A6F53C-32EE-460A-BD9A-4F5EA7175F4A

P31

Q37860806-1D81E148-30AB-49D7-80F1-EBAF2D5C2D19

P356

Q37860806-8D8BA408-221D-4C3C-AC12-DA8EAB69852C

P407

Q37860806-DD68AAD7-652B-4384-9124-4DE22581F0A7

P478

Q37860806-0530976C-BF31-4170-BCD7-BFDE4493DD88

P577

Q37860806-D7B3914C-0900-44AE-8FD1-7EDB4CDA2135

P5875

Q37860806-451BE70E-A165-4A1A-9B2E-B7FDDAB957AC

P698

Q37860806-232C74D6-2E21-4290-A1DB-F5F79D97B092

P921

Q37860806-56079394-006D-4468-AF9F-BD413FB6DF65

P356

P1433

Clinical Infectious Diseases

P1476

Procalcitonin as a biomarker in respiratory tract infection.

@en

P2093

David N Gilbert

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections

Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN731826

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes.

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

Biomarkers to improve diagnostic and prognostic accuracy in systemic infections.

Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.

Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.

Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia.

P304

S346-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIR050

http://www.w3.org/2001/XMLSchema#string

P407

P478

52 Suppl 4

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50997842

http://www.w3.org/2001/XMLSchema#string

P698

21460294

http://www.w3.org/2001/XMLSchema#string

P921